Between 2020 and 2023, a decreasing trend was observed for HPV39, 52, 58, 6, 11, and 43, with the most significant decreases observed in HPV-6 and HPV-11 (Table 1 ).
← all excerpts
Epidemiologic burden, clinical attribution, and implications for immunization strategies of HPV infection among males in Sichuan, China: a large-sample cross-sectional study.
1
—
—